<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="ijms-21-09653-t007" orientation="portrait" position="float">
 <object-id pub-id-type="pii">ijms-21-09653-t007_Table 7</object-id>
 <label>Table 7</label>
 <caption>
  <p>In vitro anticancer activity of 
   <italic>Origanum vulgare</italic> L. essential oil (OEO).
  </p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Details: Source, Phytochemical Composition; Dose, Formulation</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cancer Cell Line</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cell Proliferation, Apoptosis, Cytotoxicity, Dose, Incubation Time, Effect</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">
     <italic>Origanum vulgare</italic> L. was harvested from Chile.
     <break/>GS-MS assay of the OEO showed that 4-terpineol 41.17% was the major component, followed by thymol (21.95%), c-terpinene (5.91%), and carvacrol (4.71%).
     <break/>Cancerous cells were treated with the OEO ranging from 10 to 500 mg/mL.
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">human breast adenocarcinoma (MCF-7)
     <break/>human colon adenocarcinoma (HT-29)
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">The cytotoxicity test was performed by sulforhodamine B assay.
     <break/>Cancer cells were incubated for 72 h with OEO.
     <break/>The most effective concentration for HT-29(human colon adenocarcinoma) and MCF-7 (human breast adenocarcinoma) was 50 mg/mL and cell growth inhibition was 60.8% and 48.9%, respectively.
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">[
     <xref rid="B71-ijms-21-09653" ref-type="bibr">71</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">
     <italic>Origanum vulgare</italic> L. was collected from Basilicata Region, Southern Italy.
     <break/>According to GS-MS and GS-FID, thymol and carvacrol were the main phytocompounds (74.8%), followed by citral (2.5%).
     <break/>Tested concentrations ranged from 100 to 800 µg/µL.
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">hepatocarcinoma cell line (HepG2)
     <break/>non-tumour cell line (HEK293)
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">The cytotoxicity test was performed by MTT assay.
     <break/>They also analysed the cell morphology using phase-contrast microscopy.
     <break/>Cancer cells were incubated for 24 h with OEO 
     <break/>IC
     <sub>50</sub> = 236 µg/µL for HepG2 cells
     <break/>IC
     <sub>50</sub> = 310 µg/µL for HEK293 cells
     <break/>HepG2 cells treated with OEO (236 µg/µL, for 24 h) showed morphological changes, such as detaching in the degradation phase.
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">[
     <xref rid="B70-ijms-21-09653" ref-type="bibr">70</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">OEO was purchased from Berjé USA.
     <break/>Chemical constituents of OEO were identified by GC–MS and consisted in: 
     <break/>thymol (65.84%), 
     <break/>p-cymene (9.86%), 
     <break/>
     <italic>γ</italic>-terpinene (6.73%)
     <break/>Tested concentrations of OEO were: 5, 10, 25, 50 and 100 μg/mL.
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">human stomach cancer (AGS)</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Antiproliferative property of OEO in AGS was determined by MTT assay.
     <break/>Cancer cells were incubated for 48 h with OEO. 
     <break/>IC
     <sub>50</sub> = 13.4 μg/mL
     <break/>The best antiproliferative activity of OEO was found to be 100 μg/mL.
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">[
     <xref rid="B72-ijms-21-09653" ref-type="bibr">72</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Source of the material plant and chemical constituents were mentioned above in reference [
     <xref rid="B38-ijms-21-09653" ref-type="bibr">38</xref>].
     <break/>Tested concentrations of OEO were 50, 100, 200, 300, and 400 μg/mL
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">human breast adenocarcinoma (MCF-7)
     <break/>cervical adenocarcinoma (HeLa)
     <break/>T-cell lymphoblast (Jurkat) 
     <break/>colon adenocarcinoma (HT-29)
     <break/>urinary bladder carcinoma (T24)
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">In comparison to positive controls (vinblastine sulfate and taxol) OEO presented significant antitumoral activities against:
     <break/>MCF-7 (IC
     <sub>50</sub> = 8.11 µg/mL, taxol-IC
     <sub>50</sub> = 0.08 µg/mL), 
     <break/>HeLa (IC
     <sub>50</sub> = 13.41 µg/mL, vinblastine-IC
     <sub>50</sub> = 2.5 µg/mL) 
     <break/>Jurkat (IC
     <sub>50</sub> = 27.05 µg/mL, 
     <break/>vinblastine-IC
     <sub>50</sub> = 0,1 µg/mL)
     <break/>HT-29 (IC
     <sub>50</sub> = 12.18 µg/mL, vinblastine-IC
     <sub>50</sub> = 12.18 µg/mL)
     <break/>T24 (IC
     <sub>50</sub> = 105.5 µg/mL, vinblastine-IC
     <sub>50</sub> = 63.31 µg/mL)
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">[
     <xref rid="B38-ijms-21-09653" ref-type="bibr">38</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OEO was purchased from Edens Garden, San Clemente, CA, USA.
     <break/>OEO was encapsulated (2.5%, 5%, 7.5%) into nanofibres of PLCL/SF polymers by electrospinning
     <break/>Phytochemical constituents of the essential oils were not mentioned
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">mammary carcinoma (mouse) 4T1 cell line</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cell viability was measured by cell counting kit-8 (CCK-8) assay.
     <break/>The incubation time for the cells on the material was 24, 48, and 72 h
     <break/>NF membranes with 5% and 7.5% OEO contents presented a strong antiproliferative effect after 72 h 
     <break/>(
     <italic>p</italic> &lt; 0,05)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B61-ijms-21-09653" ref-type="bibr">61</xref>]
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
